Compare ESP & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESP | OSUR |
|---|---|---|
| Founded | 1928 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 148.8M | 174.3M |
| IPO Year | N/A | 1986 |
| Metric | ESP | OSUR |
|---|---|---|
| Price | $47.13 | $2.38 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 15.0K | ★ 688.5K |
| Earning Date | 02-11-2026 | 11-05-2025 |
| Dividend Yield | ★ 2.12% | N/A |
| EPS Growth | ★ 28.72 | N/A |
| EPS | ★ 3.16 | N/A |
| Revenue | $42,600,530.00 | ★ $125,703,000.00 |
| Revenue This Year | $9.16 | N/A |
| Revenue Next Year | $5.68 | $3.70 |
| P/E Ratio | $14.91 | ★ N/A |
| Revenue Growth | ★ 4.90 | N/A |
| 52 Week Low | $24.85 | $2.08 |
| 52 Week High | $55.00 | $4.22 |
| Indicator | ESP | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 68.61 | 43.55 |
| Support Level | $46.27 | $2.37 |
| Resistance Level | $47.77 | $2.50 |
| Average True Range (ATR) | 1.37 | 0.09 |
| MACD | 0.22 | 0.00 |
| Stochastic Oscillator | 88.83 | 13.04 |
Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.